fr en
Locations
  • Pharmaceutical Solutions
    Pharmaceutical Solutions
    • Pharmaceutical Solutions
    • Small molecules APIs
      • Small molecules APIs
      • Custom Development & Manufacturing
      • Proprietary APIs
      • Proprietary Intermediates
      • Drug Delivery & Materials
    • Consumer Health APIs
      • Consumer Health APIs
      • Acetylsalicylic Acid
      • Salicylic Acid
      • Methyl Salicylate
      • Paracetamol
      • Para Amino Phenol
      • Allyl Alcohol
    • Life science Inputs
      • Life science Inputs
      • Disinfectants & Antiseptics
      • Isopropanol (IPA)
      • Diisopropyl Ether (DIPE)
      • Isopropyl Acetate (IPAC)
      • In vitro diagnostic
  • Specialty Ingredients
    Specialty Ingredients
    • Specialty Ingredients
    • Cosmetics
      • Cosmetics
      • Custom Cosmetics
      • Active
      • Functional
    • Custom Manufacturing
      • Custom Manufacturing
      • Custom Processing
      • Fine Chemicals
      • Catalyst re-impregnation
    • Lubricant Additives
      • Lubricant Additives
      • Metalworking
      • Metal Protection
      • Custom greases
    • Electronics
      • Electronics
      • Micro-Electronics
      • Printed & Organic Electronics
    • Solvents
      • Solvents
      • Oxygenated Solvents
      • Low VOC Solvents
      • Solvent Recovery
    • Mineral Specialties
      • Mineral Specialties
      • Bicarbonates
      • Soda Ash
      • Sodium Silicates
      • Nabion
    • Upstream platform
      • Upstream platform
      • Phenol & Acetone
      • Essentials
  • R&D Services
    R&D Services
    • R&D Services
    • Market offering
      • Market offering
      • Pharma early phase development
      • Pharma late phase development
      • Custom ingredients
      • Personal care
    • Key expertise
      • Key expertise
      • Artificial Intelligence
      • Biocatalysis
      • Multi-catalysis
      • Flow Chemistry
      • Polymers
      • High-Potency APIs (HPAPIs)
      • Solid state
    • R&D Excellence centres
      • R&D Excellence centres
      • Seqens'Lab
      • Protéus (Biocatalysis)
      • Boston’Lab (Early phase projects)
      • Aramon'Lab (Drug Delivery Polymers)
      • Montreal' Lab (Electronics)
    • Business Partners hosting
      • Business Partners hosting
      • Drug repositionning
      • Toxicology
  • About Seqens
    About Seqens
    • SEQENS GROUP
    • OUR HISTORY
    • OUR VALUES
    • GROUP GOVERNANCE
    • SCIENTIFIC COMMITTEE
    • OUR PARTNERS
  • Material safety data sheet
  • Careers
    Careers
    • JOBS
    • SPONTANEOUS APPLICATION
  • Newsroom
  • Contact
fr en
logo-seqens
Locations Products Commitments
logo-seqens
  • Pharmaceutical Solutions
    Pharmaceutical Solutions
    • Small molecules APIs
      • Custom Development & Manufacturing
      • Proprietary APIs
      • Proprietary Intermediates
      • Drug Delivery & Materials
    • Consumer Health APIs
      • Acetylsalicylic Acid
      • Salicylic Acid
      • Methyl Salicylate
      • Paracetamol
      • Para Amino Phenol
      • Allyl Alcohol
    • Life science Inputs
      • Disinfectants & Antiseptics
      • Isopropanol (IPA)
      • Diisopropyl Ether (DIPE)
      • Isopropyl Acetate (IPAC)
      • In vitro diagnostic
  • Specialty Ingredients
    Specialty Ingredients
    • Cosmetics
      • Custom Cosmetics
      • Active
      • Functional
    • Custom Manufacturing
      • Custom Processing
      • Fine Chemicals
      • Catalyst re-impregnation
    • Lubricant Additives
      • Metalworking
      • Metal Protection
      • Custom greases
    • Electronics
      • Micro-Electronics
      • Printed & Organic Electronics
    • Solvents
      • Oxygenated Solvents
      • Low VOC Solvents
      • Solvent Recovery
    • Mineral Specialties
      • Bicarbonates
      • Soda Ash
      • Sodium Silicates
      • Nabion
    • Upstream platform
      • Phenol & Acetone
      • Essentials
  • R&D Services
    R&D Services
    • Market offering
      • Pharma early phase development
      • Pharma late phase development
      • Custom ingredients
      • Personal care
    • Key expertise
      • Artificial Intelligence
      • Biocatalysis
      • Multi-catalysis
      • Flow Chemistry
      • Polymers
      • High-Potency APIs (HPAPIs)
      • Solid state
    • R&D Excellence centres
      • Seqens'Lab
      • Protéus (Biocatalysis)
      • Boston’Lab (Early phase projects)
      • Aramon'Lab (Drug Delivery Polymers)
      • Montreal' Lab (Electronics)
    • Business Partners hosting
      • Drug repositionning
      • Toxicology
Top of page
  • About Seqens
  • Material safety data sheet
  • Careers
  • Newsroom
  • Contact

SEQENSgroup

  • SEQENS GROUP
  • OUR HISTORY
  • OUR VALUES
  • GROUP GOVERNANCE
  • SCIENTIFIC COMMITTEE
  • OUR PARTNERS
  • JOBS
  • SPONTANEOUS APPLICATION
Share

Newsroom

Home Newsroom
General / Press Release Covid-19

COVID – 19 LATEST UPDATES

07th may 2020

SEQENS mobilizes its innovation to support the unprecedented research on the covid-19 and prepares its unique industrial network for anti-virus production, for…

Read more
General / Protéus / SD-CSR 26th october 2020

Protéus by Seqens winner of the Potier Prize 2020

This year, the Pierre Potier 2020 prize was awarded to Protéus by Seqens, the group’s biotech subsidiary specialized in enzymatic biocatalysis,…

Read more
Protéus 15th september 2020

Conference: “Biocatalysis from lab to industrial scale”

On July 27th, during the Protein Engineering Congress USA, Protéus by Seqens gave a talk on « Biocatalysis from lab to industrial scale », right…

Read more
General / Protéus 30th june 2020

Biocatalysis Webinar – Protéus by Seqens – Pôle IAR – May 6th, 2020

REPLAY OF THE WEBINAR About BIOCATALYSIS On May 6th, Proteus by Seqens co-organized, together with the French bioeconomy cluster IAR a webinar on…

Read more
General / Protéus 05th june 2020

A new article published by Proteus in the special issue of OPRD journal

engineering of enzymatic cascades from D-serine This special issue highlights innovative organic chemistry research from academic and industrial chemists across France and its…

Read more
General / Products & Technologies / Protéus Covid-19 15th may 2020

What flow chemistry and biocatalysis bring to synthesize a typical small molecule candidate against Covid-19 epidemic

Efficient and safe process design combining SEQENS technical capabilities: Brilacidin as a case study As already mentioned in our previous article (“Seqens…

Read more
General / Products & Technologies / Protéus Covid-19 30th april 2020

SEQENS biocatalytic approach to improve the synthesis of Danoprevir, a Covid-19 antiviral candidate

Focusing on biocatalysis for asymmetric synthesis and precious metal catalysts replacement The covid-19 crisis triggered an unprecedented mobilization of pharmaceutical research. Mid-April, 440…

Read more
General / Protéus 03rd april 2020

Futurol’s first contract for a second-generation ethanol plant in Croatia

AXENS and the Croatian oil company INA announced on 09 March 2020 an agreement for the construction of a 55 kt/year second…

Read more
General / Press Release / Products & Technologies / Protéus 11th december 2019

Protéus by Seqens launches SEQENZYM®

Protéus by Seqens launches SEQENZYM®, Enzyme Kits selected among an extensive library of Extremophile Strains for Fast Early Screening of Biocatalysts…

Read more
General / Protéus 20th june 2019

Enzymatic neutralization of endocrine disrupting activity of potent compounds

Reducing micropollutants, such as endocrine disruptors, is one of key issues in environmental management. Their presence in the environment, is most often related…

Read more
General / Protéus 29th may 2019

Applying Enzymatic Synthesis for Chiral Molecules

Pharma’s Almanac Magazine Advances in our understanding of enzymatic transformations and the increased availability of enzymes engineered for use in fine chemical synthesis…

Read more

Join the SEQENS teams !

See our job offers

A question? A need?Contact us

Contact us

Follow the seqens evolution onsocial medias

  • Home
  • Newsroom
  • Press / Media
  • About cookies
  • GTC
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.

Gérer mes préférences

Certaines des fonctionnalités de ce site (partage de contenu sur les réseaux sociaux, lecture vidéo en direct) sont basées sur des services fournis par des sites tiers. Ces fonctions stockent des cookies qui permettent à ces sites de suivre votre navigation. Ces cookies ne sont stockés que si vous donnez votre consentement. Vous pouvez vous renseigner sur la nature des cookies placés, les accepter ou les refuser soit globalement pour l'ensemble du site et tous les services, soit service par service.

Cookies obligatoires

Cookies d'analyse d'audience

Cookies liés aux réseaux sociaux

Enregistrer
Ok

DISCOVER OUR NEWS

Learn more